Recent Updates
Recently added Catalysts
ATEC Positive Sentiment

ATEC Reports Second Quarter Financial Results

Tuesday, August 4, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Alphatec Holdings, Inc. reported its financial results for Q2 2026, showcasing total revenue of $214 million. The company achieved a GAAP gross margin of 72.2% and a non-GAAP gross margin of 72.5%. However, operating expenses were notably high at $156 million, which could affect profitability moving forward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Total revenue reached $214 million, indicating strong sales performance.
  • GAAP gross margin is high at 72.2%, reflecting efficient operations.
  • Non-GAAP gross margin slightly higher at 72.5%, suggesting solid profitability.

CONCERNS & RISKS

  • GAAP operating expenses are significant at $156 million, impacting net income.
  • High operating expenses may raise concerns about future profitability.

Full Press Release Details

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2026, and business highlights. Second Quarter 2026 Financial Results Quarter Ended June 30, 2026 Total revenue $214 million GAAP gross margin 72.2% Non-GAAP gross margin 72.5% GAAP operating expenses $156 million Non-GAAP operating expenses $135 mill

Frequently Asked Questions

What was Alphatec's total revenue for Q2 2026?

Alphatec's total revenue for Q2 2026 was $214 million.

What is the GAAP gross margin reported by ATEC?

The GAAP gross margin reported by ATEC is 72.2%.

How much were Alphatec's operating expenses in Q2 2026?

Alphatec's operating expenses for Q2 2026 were $156 million.

What does non-GAAP gross margin indicate for ATEC?

The non-GAAP gross margin for ATEC was 72.5%, indicating strong profitability.

ShareAdd on Google
Tags: ATEC Viatris Investor Conferences Healthcare Alphatec Holdings spine surgery financial results Q2 2026
Last updated: Aug 4, 2026

Biotech snapshot

Cash runway
$140M liquidity · $0M/mo burn
Low dilution risk